Effects of different amounts of mindfulness meditation on well-being
Examining Dose-Response Effects of Mindfulness Meditation Interventions on Wellbeing: A Randomized Controlled Trial
This study is testing if different amounts of mindfulness meditation can improve well-being in healthy adults who haven't meditated much before.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 860 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Melbourne Academic / other |
| Locations | 1 site (Carlton, Victoria) |
| Trial ID | NCT06378450 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial aims to investigate the dose-response effects of mindfulness meditation on well-being in healthy adults with little to no prior meditation experience. Participants will be assigned to one of four groups receiving varying durations of daily meditation practice—10, 20, or 30 minutes, or a minimal dose of 3-4 minutes—over a 28-day period. The study will assess changes in well-being through self-reported measures at multiple time points, while also monitoring participant engagement and adherence to the meditation regimen. The goal is to determine whether longer meditation sessions lead to greater improvements in psychological well-being.
Who should consider this trial
Good fit: Ideal candidates are healthy adults residing in Australia with minimal prior experience in meditation.
Not a fit: Patients with severe anxiety or depression symptoms may not benefit unless they are receiving ongoing treatment for their conditions.
Why it matters
Potential benefit: If successful, this study could provide insights into optimal meditation practices that enhance well-being and mental health.
How similar studies have performed: Previous studies have shown positive effects of mindfulness meditation on well-being, but this specific dose-response approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Reside in Australia, with no plans to relocate or travel overseas during the intervention period; * Sufficient comprehension of the English language to complete measures; * Register for an account and agree to the Terms and Conditions of Unforgettable.Me; * If suffering anxious or depressive symptoms of moderate severity (defined by \> 19 on the Patient-Reported Outcomes Measurement Information System \[PROMIS\] Level 2 Anxiety or \> 22 on the PROMIS Level 2 Depression), must agree to continue recommended routine medical treatment for eligible underlying mental and/or physical health conditions or the duration of the study and to seek additional treatment if indicated by deterioration of symptoms; * No or minimal experience with meditation, defined as less than 25 hours over the past 6 months; never attended a multi-day mindfulness course (e.g., Mindfulness-Based Stress Reduction, Vipassana). If 50% of our target sample size has not bee recruited within the first three months of active recruitment, the inclusion criteria will be broadened to include participants with up to 100 hours in the past 6 months. Exclusion Criteria: * Self-reported current or lifetime serious mental illness (e.g., neurodevelopmental, schizophrenia spectrum, bipolar, obsessive-compulsive, trauma-related, dissociative or personality disorder); * Anxious and depressive symptoms in the severe range (defined by \>27 on the PROMIS Level 2 Anxiety or \> 32 on the PROMIS Level 2 Depression); * Psychological distress symptoms in the severe range (Kessler Psychological Distress Scale \[K10\] \>= 30); * Threshold scores on pre-screening and follow-up measures exceeded for Mania, Suicidal Ideation, Psychosis, Repetitive Thoughts \& Behaviors, Dissociation * Moderate alcohol, tobacco, or drug use; * Self-reported diagnosis of neurological condition (e.g., traumatic brain injury, amnesia, epilepsy, stroke, etc.); * Self-reported presence of any serious medical condition (e.g., cancer, thyroid disorder, multiple sclerosis, etc.); * Recent bereavement or major loss; * History of unexplored, untreated traumatic experiences or adverse childhood events.
Where this trial is running
Carlton, Victoria
- Contemplative Studies Centre, The University of Melbourne — Carlton, Victoria, Australia (Recruiting)
Study contacts
- Principal investigator: Nicholas T Van Dam — University of Melbourne
- Study coordinator: Nicholas T Van Dam, PhD
- Email: nicholas.vandam@unimelb.edu.au
- Phone: +61 3 8344 3644
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.